2026-10-25
ePlus inc. clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 29,699 +0.16%
S&P 7,740 +0.22%
GOLD $4,054 −0.50%
BTC $80,483 −0.40%
VIX 17.23 −1.66%
latest tape · as of 16:01 UTC
The Screen · Technology
ePlus inc.
PLUS · Nasdaq · USD · Market cap $2.5B
Not yet scored95.81 USD
Price as of 27 Oct 2026Daily close, not a live quote
Screened 2026-10-27 · the tape above runs as of 16:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price95.81 USD at the 27 Oct 2026 close
- Ethical screenNot yet scored
- OptionsOpen interest leans heavily to calls (put/call 0.26)
- Last reviewed27 Oct 2026 (1 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 95.81 against the desk's fair-value range, base estimate 111.00, over the last year.
- Trend Accumulation
- Insiders insiders sold, $481,455, latest filing 2026-10-12
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.26, read 2026-10-27
- Ethical screen not yet scored
Price95.81 USD
Fair value111.00
Our investment reviews on this name
2026-10-28Read Accumulation95.81+0.0% to today ✓Markdown gives way to Accumulation
2026-10-21Read Markdown94.97+0.9% to today Accumulation gives way to Markdown while volume still accumulates
2026-09-09Read Accumulation92.10+4.0% to today ✓Markup gives way to Accumulation after a 12% rise in 10 weeks
2026-07-02Read Markup82.32+16.4% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its accumulation label.
ePlus inc. holds its Accumulation at $95.81. Consolidating, no directional conviction, held for 82 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 82 days |
| Price at the screen | $95.81 |
| Valuation | 20.56 trailing · 16.09 forward price to earnings |
| Values screen | Not scored |
| Beta | 0.97 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 5.95% | Below 33% | Interest-bearing debt is just 6.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 14.59% | Below 33% | Cash held in interest-bearing accounts and securities is 14.6% of assets, under the one-third limit. | Pass |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
ePlus inc. clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
ePlus inc. clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 6%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-10-27 screen. The gold marker is the market price at the same screen. A 15.9% margin of safety to the base estimate.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsIT Reseller Offers Growth at a Discount
Picture a company helping businesses sort their servers, software and cloud moves without the big vendor runaround. ePlus shows revenue climbing 22% while trading at a forward P/E of 15.4x against a fair value that sits 24% higher. Moderate moat, 12% ROE and a clean ethical pass add to the case for steady compounding rather than headline drama.
The single analyst target lines up with that same $111 level, yet the 5% profit margin leaves little room for slippage in a competitive tech supply chain. Currency moves or a slowdown in corporate IT budgets could pressure results faster than the numbers suggest today.
Margins and analyst coverage both look thin next to the growth rate, so any investment case stays tied to execution rather than broad sector tailwinds. Analysis, not advice.
| Forward P/E | 16.1xexpensive even after accounting for its growth |
| Trailing P/E | 20.6xa premium valuation |
| EPS, trailing | 4.66 |
| EPS, forward | 5.96 |
| Revenue growth | +1.0%slow but positive growth |
| Profit margin | 4.9%barely profitable |
| Return on equity | 11.7%a modest return on shareholder capital |
| FCF yield | 1.57% |
| Dividend yield | 122.00% |
| Debt to equity | 0.11minimal debt: a conservative balance sheet |
| Current ratio | 2.13comfortably covers its short-term bills |
| Beta | 0.97steadier than the market |
| Short interest, float | 0.06% |
| 52-week range | 70.96 - 98.21 |
| Moat | MODERATE |
| Market cap | $2.5B |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradePLUS trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-10-28
Accumulation · changed $95.81
+0.9% Entry 9
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.9% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (1 analysts) rates it strong buy, with a mean price target of $115.
2026-10-21
Markdown · changed $94.97
-2.0% Entry 8
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (1 analysts) rates it strong buy, with a mean price target of $115.
2026-10-14
Accumulation $96.93
+6.3% Entry 7
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 6.3% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (1 analysts) rates it strong buy, with a mean price target of $115.
2026-10-02
Accumulation $91.16
-1.0% Entry 6
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (1 analysts) rates it strong buy, with a mean price target of $115.
2026-09-09
Accumulation · changed $92.10
-5.1% Entry 5
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 5.1% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (1 analysts) rates it strong buy, with a mean price target of $115.
2026-08-08
Markup $97.05
+17.9% Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 17.9% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (1 analysts) rates it strong buy, with a mean price target of $115.
2026-07-18
Markup $82.32
+0.0% Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (1 analysts) rates it strong buy, with a mean price target of $115.
2026-07-03
Markup $82.32
+0.0% Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns.
2026-07-02
Markup $82.32
Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Manulife Investments Announces October 2026 Cash Distributions for Manulife Exchange Traded Funds and ETF Series of Manulife Funds Yahoo Finance · 5d ago
- ePlus Named NetApp North America Flash Partner of the Year Yahoo Finance · 8d ago
- 1 Profitable Stock with Solid Fundamentals and 2 We Ignore Yahoo Finance · 15d ago
- 2 Services Stocks with Exciting Potential and 1 We Turn Down Yahoo Finance · 19d ago
- 1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds Yahoo Finance · 23d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
APELYAlps Alpine Co., Ltd.
BHEBenchmark Electronics, Inc.
EEFTEuronet Worldwide, Inc.
ROGRogers Corporation
BLKBBlackbaud, Inc.
DXCDXC Technology Company
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-12 | Marion Elaine D | CFO | S - Sale | 5,000 | $481,455 |
| 2026-09-22 | Raiguel Darren S | COO | S - Sale | 1 | $93 |
| 2026-05-11 | RAIGUEL DARREN S | Chief Operating Officer | 1,284 | $115,314 | |
| 2026-05-06 | RAIGUEL DARREN S | Chief Operating Officer | 5 | $440 | |
| 2026-04-01 | BOWEN BRUCE M | Director | 283 | · | |
| 2026-02-10 | RAIGUEL DARREN S | Chief Operating Officer | 711 | $62,802 | |
| 2026-01-05 | PORTEGELLO MICHAEL JOSEPH | Director | 894 | · | |
| 2026-01-02 | BOWEN BRUCE M | Director | 248 | · | |
| 2025-12-31 | RAIGUEL DARREN S | Chief Operating Officer | 82 | $7,191 | |
| 2025-12-31 | STOECKER ERICA STEINACKER | General Counsel | 8 | $702 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $89.00 | -6.5% | · | $935 | -6.5% |
| 2 months | $81.39 | +2.3% | · | $1,023 | +2.3% |
| 3 months | $76.19 | +9.2% | · | $1,092 | +9.2% |
| 6 months | $92.78 | -10.3% | $0.25 | $900 | -10.0% |
| 1 year | $72.12 | +15.4% | $0.75 | $1,164 | +16.4% |
| 2 years | $72.23 | +15.2% | $0.75 | $1,163 | +16.3% |
| 3 years | $54.48 | +52.8% | $0.75 | $1,541 | +54.1% |
| 5 years | $45.34 | +83.5% | $0.75 | $1,852 | +85.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever PLUS does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.